Title
Category
Credits
Event date
Cost
Bridging the Bench and Bedside: The Amalgam of Academic Medicine and Its Effect on a Cancer Patient Experience - SPOC
  • SAICEP
  • 1.00 Participation
$0.00
Webinar DescriptionHannah E. Woriax, MD, will review several case scenarios and patient archetypes that have had their treatment course changed drastically due to recent landmark research studies. Dr. Woriax will then go through a few scenarios relevant to my current patient population specifically. Based on these patient scenarios, she will then discuss potential research possibilities for the future.
Basics of EKG Interpretation with an Oncology Focus - SPOC
  • Advanced Practice Provider
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Tracy Vernon-Platt, DNP, ANP-BC, will provide a systematic approach to EKG interpretation. It will also discuss common arrhythmias in patients with cancer, identification of the arrhythmias, and management strategies.
Tailoring Care for the Evolving Needs of Cancer Survivors - SPOC
  • Advanced Practice Provider
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Tammy Triglianos, DNP, ANP-BC, AOCNP, and Mary Dunn, MSN, RN, OCN, NP-C, will highlight the multifaceted challenges faced by cancer survivors and emphasize the importance of personalized care. By examining the physical, emotional, and social needs that evolve over time, they will discuss strategies for approaches to care, including interdisciplinary collaboration, to improve quality of life.
Prostate Cancer 101 - GU Oncology Nursing Education - Part 2
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
In this course, Mary Dunn, MSN, RN, NP-C, OCN, will go into more detail for treatment options and considerations for treating localized prostate cancer and the management of side effects.
Prostate Cancer 101 - GU Oncology Nursing Education - Part 1
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
In this course, Mary Dunn, MSN, RN, NP-C, OCN, will provide a general overview of Prostate Cancer. The audience will learn about basic pathophysiology and epidemiology as it relates to both local and advanced disease. This course will then provide insight into the pros & cons of prostate cancer screening as well as the accepted diagnostic procedures & scoring.
Prostate Cancer 101 - GU Oncology Nursing Education - Part 3
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
In this course, Mary Dunn, MSN, RN, NP-C, OCN, will discuss the different treatment options for advanced prostate cancer as well as considerations for management side effects and maximizing a survivor’s quality of life.
The Ketogenic Diet for Brain Tumor Patients: A Phase 1 Trial and Beyond... - SPOC
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Jethro Hu, MD, will review the rationale and current evidence supporting the potential role of a ketogenic diet for brain tumor patients, focusing on a recently completed phase 1 safety and feasibility trial.
Cancer Screening in Primary Care - SPOC
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Noelle Robertson, MD, CAQSM presents an evidence-based review of outpatient primary care screening for breast, colon, lung and prostate cancer.
The Expanding World of Cellular Therapy - SPOC
  • Advanced Practice Provider
  • 1.25 NCPD/CNE
  • 1.00 Participation
$0.00
Cellular therapy as a form of immunotherapy is a rapidly growing field for a variety of diseases. Brianne Buchanan, PA-C, will survey some of the latest research involving CAR-T and similar cellular therapies that can go from the bench to the bedside. She will also describe the wide range of cellular therapy options available to consider these for patients.
Current Concepts in Spinal Oncology - SPOC
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.25 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Michael Galgano, MD, FAANS, will focus on differentiating the various types of spinal tumors, ranging from metastases, to primary vertebral column tumors, and intradural spinal cord tumors. He will discus the contributions of co-morbidities and frailty on the management of patients with spinal tumors. He will also aim to give the audience a brief exposure to the surgical management of spinal oncology, and what is entailed to execute robust local control.

Pages